Saroja Pharma Ind

SAROJA

Q: How strong is Saroja Pharma Ind balance sheet?

Balance sheet of Saroja Pharma Ind is strong.It shouldn't have solvency or liquidity issues.

Q: Is the debt of Saroja Pharma Ind increasing or decreasing?

Yes, The debt of Saroja Pharma Ind is increasing.Latest debt of Saroja Pharma Ind is ₹7.41 Crs as of Sep-24.This is greater than Mar-24 when it was ₹5.14 Crs.

Q: Is Saroja Pharma Ind stock expensive?

Saroja Pharma Ind is not expensive.Latest PE of Saroja Pharma Ind is 20.05, while 3 year average PE is 21.52. Also latest EV/EBITDA of Saroja Pharma Ind is 0 while 3yr average is 6.59.

Price

Micro Cap

₹15 Cr.

New to Zerodha? Sign-up for free.

Saroja Pharma Industries India Limited is a leading trader, exporter, and supplier of Specialty Chemicals. They focus on providing superior quality chemicals with excellent effectiveness, shelf life, and composition. The company's objective is to offer the best services in chemical trading to premium pharmaceutical companies in India and abroad for cost-eff… More

Saroja Pharma Industries India Limited is a leading trader, exporter, and supplier of Specialty Che… More

Low

33.10

52W Range

High

70.75

17.17

Sector PE

25.37

P/B

Div.Yield

ROE

6.0%

EBIDTA

ROCE

15.38

EPS

New to Zerodha? Sign-up for free.

Share Price
Financials
Revenue mix
Shareholdings
Peers
Forensics

This data is currently unavailable for this company.

Summary
Profit & Loss
Balance sheet
Cashflow

View Detailed Summary

This data is currently unavailable for this company.

Yearly | Quarterly

(In Cr.)

(In Cr.)
This data is currently unavailable for this company.

Financial Ratio's

(In %)

Detailed P&L Report

(In Cr.)

Detailed Balance Sheet

Financial Year (In Cr.)

Detailed Cash Flow

Product wise
Location wise

SAROJA
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

SAROJA
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

More Info

Shareholdings

Holders

Detailed Shareholdings

This data is currently unavailable for this company.

Peers

Detailed Peers

Forensics

View Detailed Forensics

Recent events

News
Corporate Actions

This data is currently unavailable for this company.

Events:

Quarterly Results

Announcement Date

Nov 09, 2023

More Micro Cap Ideas

See similar 'Micro' cap companies with recent activity

Promoter Buying

Companies where the promoters are bullish

Detailed List

Capex

Companies investing on expansion

Detailed List

Superstar Investor

Companies where well known investors have invested

Detailed List

Popular questions

Business
Financials
Share Price
Shareholdings

What does Saroja Pharma Ind do?

Saroja Pharma Industries India Limited specializes in trading and exporting Specialty Chemicals for pharmaceutical products. Dedicated to delivering cost-effective human and veterinary medicines with superior quality and service.

Who are the competitors of Saroja Pharma Ind?

Saroja Pharma Ind major competitors are Emmessar Biotech&Nut, Parmax Pharma, Norris Medicines, Hamps Bio, Phaarmasia, Link Pharma Chem, Chemo Pharma Labs. Market Cap of Saroja Pharma Ind is ₹18 Crs. While the median market cap of its peers are ₹17 Crs.

Is Saroja Pharma Ind financially stable compared to its competitors?

Saroja Pharma Ind seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Does Saroja Pharma Ind pay decent dividends?

The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Saroja Pharma Ind latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

How has Saroja Pharma Ind allocated its funds?

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress, Accounts Receivable

How strong is Saroja Pharma Ind balance sheet?

Balance sheet of Saroja Pharma Ind is strong. It shouldn't have solvency or liquidity issues.

Is the profitablity of Saroja Pharma Ind improving?

No, profit is decreasing. The profit of Saroja Pharma Ind is ₹0.71 Crs for TTM, ₹0.88 Crs for Mar 2024 and ₹1.06 Crs for Mar 2023.

Is the debt of Saroja Pharma Ind increasing or decreasing?

Yes, The debt of Saroja Pharma Ind is increasing. Latest debt of Saroja Pharma Ind is ₹7.41 Crs as of Sep-24. This is greater than Mar-24 when it was ₹5.14 Crs.

Is Saroja Pharma Ind stock expensive?

Saroja Pharma Ind is not expensive. Latest PE of Saroja Pharma Ind is 20.05, while 3 year average PE is 21.52. Also latest EV/EBITDA of Saroja Pharma Ind is 0 while 3yr average is 6.59.

Has the share price of Saroja Pharma Ind grown faster than its competition?

Saroja Pharma Ind has given lower returns compared to its competitors. Saroja Pharma Ind has grown at ~4.41% over the last 1yrs while peers have grown at a median rate of 7.0%

Is the promoter bullish about Saroja Pharma Ind?

Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Saroja Pharma Ind is 73.02% and last quarter promoter holding is 73.02%.

Are mutual funds buying/selling Saroja Pharma Ind?

There is Insufficient data to gauge this.

SAROJA

Share Price

Financials

Revenue mix

Shareholdings

Peers

Forensics

Summary

Profit & Loss

Balance sheet

Cashflow

Product wise

Location wise

Recent events

News

Corporate Actions

Events:

Quarterly Results

More Micro Cap Ideas

Promoter Buying

Capex

Superstar Investor

Popular questions

Business

Financials

Share Price

Shareholdings

What does Saroja Pharma Ind do?

Who are the competitors of Saroja Pharma Ind?

Is Saroja Pharma Ind financially stable compared to its competitors?

Does Saroja Pharma Ind pay decent dividends?

How has Saroja Pharma Ind allocated its funds?

How strong is Saroja Pharma Ind balance sheet?

Is the profitablity of Saroja Pharma Ind improving?

Is the debt of Saroja Pharma Ind increasing or decreasing?

Is Saroja Pharma Ind stock expensive?

Has the share price of Saroja Pharma Ind grown faster than its competition?

Is the promoter bullish about Saroja Pharma Ind?

Are mutual funds buying/selling Saroja Pharma Ind?